Lori Mercurio

Lori Mercurio currently serves as the VP of Corporate Strategy and Business Development at NorthStar Medical Radioisotopes, LLC, a position held since December 2024. Prior experience includes roles at Thermo Fisher Scientific as VP of Strategy and Strategic Initiatives, where leadership was provided for the Pharma Services Group, and a significant tenure at Mallinckrodt Pharmaceuticals, where positions ranged from Senior Director of Business Development and Licensing to various director roles focused on strategic initiatives and procurement operations. Earlier career experience includes key positions at Covidien, KV Pharmaceutical, and Sanofi, emphasizing quality management, project management, and product development. Lori Mercurio holds an Executive MBA from Washington University in St. Louis, a BS in Biology from the University of Missouri-Saint Louis, and a Master's degree in Quality Management from Webster University.